Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 338 participants.
Also called NCT05744219
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 338 participants
- Sponsor
- Jon Unosson
- Registry
-
NCT05744219
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT05744219. Randomized; quadruple masking; primary purpose treatment. Start 2024-09-04 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
- Acronym
- IRIS
- Condition
- Surgery
- Condition
- Liver Metastases
- Condition
- Liver Cancer
- Condition
- Pancreas Cancer
- Condition
- Aortic Aneurysm
- Intervention (Drug)
- Ferric carboxymaltose
- Intervention (Drug)
- Placebo
- Lead sponsor
- Jon Unosson
Record details
- Record id
cardio:ct-nct05744219- Content hash
891d761656caec89cccaaa72690b021a34bec393e9c02c6df513f769b80c51f3